Kuros Biosciences Investors

15 investors on Angel Roster list Kuros Biosciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Switzerland and the Netherlands.

Investors are matched on the company name in their portfolio, so companies that share the name Kuros Biosciences can appear together.

Investors listed
15
With verified email
27%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Kuros Biosciences investors

The most complete profiles first. Showing 15 of 15.

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Alain NicodVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Paulina HillVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Francesco Draetta

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Katie Kerfoot

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Michelle Doig

    Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Arnd Kaltofen

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Benedikt Luhmann

    Venture Capital · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Diego Braguglia

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Kuros Biosciences investors are on Angel Roster?

Angel Roster lists 15 Kuros Biosciences investors. 4 of them (27%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (13) and Private Equity Firms (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Kuros Biosciences investors invest in?

Among those that list a stage, the most common are Seed (5) and Series B (3).

Where are Kuros Biosciences investors based?

Most are based in the United States (5), Switzerland (4) and the Netherlands (3).

Which companies have Kuros Biosciences investors backed?

The most-backed portfolio companies among them are eTheRNA immunotherapies (11), Immunic (11), FoRx Therapeutics (11), JenaValve Technology (10) and Sequana Medical (9).

How do I contact Kuros Biosciences investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.